Comparison of refugee patients with cystic fibrosis and their counterpart children from Turkey during the war

dc.contributor.authorYılmaz A.İ.
dc.contributor.authorPekcan S.
dc.contributor.authorEyüboğlu T.Ş.
dc.contributor.authorHangül M.
dc.contributor.authorArslan H.
dc.contributor.authorKılınç A.A.
dc.contributor.authorÇokuğraş H.
dc.contributor.authorArık E.
dc.contributor.authorKeskin Ö.
dc.contributor.authorÖzdemir A.
dc.contributor.authorErsoy M.
dc.contributor.authorErsoy A.
dc.contributor.authorKöse M.
dc.contributor.authorÖzsezen B.
dc.contributor.authorÜnal G.
dc.contributor.authorErcan Ö.
dc.contributor.authorGirit S.
dc.contributor.authorOksay S.C.
dc.contributor.authorGökdemir Y.
dc.contributor.authorKaradağ B.
dc.contributor.authorŞen V.
dc.contributor.authorÇakır E.
dc.contributor.authorYüksel H.
dc.contributor.authorTekin M.N.
dc.contributor.authorAslan A.T.
dc.date.accessioned2024-07-22T08:01:28Z
dc.date.available2024-07-22T08:01:28Z
dc.date.issued2024
dc.description.abstractSince the outbreak of the Syrian civil war in 2011, the population of Arab refugees in Turkey has rapidly increased. While cystic fibrosis (CF) is believed to be rare among Arabs, recent studies suggest it is underdiagnosed. This study aims to present the demographic, clinical, and genetic characteristics of CF patients among Arab refugees in Turkey. Additionally, a comparison is made between the findings in the National CF Registry 2021 in Turkey (NCFRT) and the refugee CF patient group. The study included refugee patients between the ages of 0 and 18 years who were diagnosed with CF and received ongoing care at pediatric pulmonology centers from March 2011 to March 2021. The study examined demographic information, age at diagnosis, age of diagnosis of patients through CF newborn screening (NBS), presenting symptoms, CF transmembrane conductance regulator (CFTR) mutation test results, sputum culture results, weight, height, and body mass index (BMI) z score. Their results were compared with the NCFRT results. The study included 14 pediatric pulmonology centers and 87 patients, consisting of 46 (52.9%) boys and 41 (47.1%) girls. All of the patients were Arab refugees, with 80 (92%) being Syrian. All the patients were diagnosed in Turkey. The median age at diagnosis of patients was 22.33 (interquartile range, 1–258) months. The median age of diagnosis of patients through NBS was 4.2 (interquartile range, 1–12) months. The median age of older patients, who were unable to be included in the NBS program, was 32.3 (interquartile range, 3–258) months. Parental consanguinity was observed in 52 (59.7%) patients. The mutation that was most frequently found was F508del, which accounted for 22.2% of the cases. It was present in 20 patients, constituting 32 out of the total 144 alleles. There was a large number of genetic variations. CFTR genotyping could not be conducted for 12 patients. These patients had high sweat tests, and their genetic mutations could not be determined due to a lack of data. Compared to NCFRT, refugee patients were diagnosed later, and long-term follow-up of refugee CF patients had significantly worse nutritional status and pseudomonas colonization. Conclusion: Although refugee CF patients have equal access to NBS programs and CF medications as well as Turkish patients, the median age at diagnosis of patients, the median age of diagnosis of patients through NBS, their nutritional status, and Pseudomonas colonization were significantly worse than Turkish patients, which may be related to the difficulties of living in another country and poor living conditions. The high genetic heterogeneity and rare mutations detected in the refugee patient group compared to Turkish patients. Well-programmed NBS programs, thorough genetic studies, and the enhancement of living conditions for refugee patients in the countries they relocate to can have several advantages such as early detection and improved prognosis. (Table presented.) © The Author(s) 2024.
dc.identifier.DOI-ID10.1007/s00431-024-05431-8
dc.identifier.issn03406199
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/11465
dc.language.isoEnglish
dc.publisherSpringer Science and Business Media Deutschland GmbH
dc.rightsAll Open Access; Hybrid Gold Open Access
dc.subjectAdolescent
dc.subjectChild
dc.subjectChild, Preschool
dc.subjectCystic Fibrosis
dc.subjectCystic Fibrosis Transmembrane Conductance Regulator
dc.subjectFemale
dc.subjectHumans
dc.subjectInfant
dc.subjectInfant, Newborn
dc.subjectMale
dc.subjectMiddle Eastern People
dc.subjectNeonatal Screening
dc.subjectRefugees
dc.subjectSyrian people
dc.subjectTurkey
dc.subjectcystic fibrosis transmembrane conductance regulator
dc.subjectdornase alfa
dc.subjectmultivitamin
dc.subjectpancreas enzyme
dc.subjectcystic fibrosis transmembrane conductance regulator
dc.subjectaccess to treatment
dc.subjectadolescent
dc.subjectadult
dc.subjectallele
dc.subjectArab
dc.subjectArticle
dc.subjectbacterial colonization
dc.subjectchild
dc.subjectcomparative study
dc.subjectconsanguinity
dc.subjectcystic fibrosis
dc.subjectfemale
dc.subjectfollow up
dc.subjectgene mutation
dc.subjectgenetic heterogeneity
dc.subjectgenetic variation
dc.subjectgenotyping
dc.subjecthuman
dc.subjectinfant
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmethicillin resistant Staphylococcus aureus
dc.subjectmethicillin susceptible Staphylococcus aureus
dc.subjectmulticenter study (topic)
dc.subjectnewborn
dc.subjectnewborn screening
dc.subjectnonhuman
dc.subjectnutritional status
dc.subjectpoverty
dc.subjectprognosis
dc.subjectPseudomonas aeruginosa
dc.subjectrefugee
dc.subjectretrospective study
dc.subjectsputum culture
dc.subjectsweat test
dc.subjectsymptomatology
dc.subjectSyrian
dc.subjectTurkey (republic)
dc.subjectTurkish citizen
dc.subjectwar
dc.subjectcystic fibrosis
dc.subjectgenetics
dc.subjectMiddle Eastern (person)
dc.subjectpreschool child
dc.subjectprocedures
dc.subjectturkey (bird)
dc.titleComparison of refugee patients with cystic fibrosis and their counterpart children from Turkey during the war
dc.typeArticle

Files